Nipro Corporation
Research Nipro Corporation (8086.T) on Bullrun: market cap JPY 224.75B, P/E 17.9, dividend yield 2.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker8086.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyJPY
- Market capJPY 224.75B
- P/E17.9
- Dividend yield2.3%
- Financial periodFY2026
- RevenueJPY 660.54B
- Revenue growth2.5%
- Net incomeJPY 13.50B
- Free cash flowJPY 54.66B
- Gross margin31.5%
Valuation Snapshot
latest market cap is JPY 224.75B; P/E is 17.9; dividend yield is 2.3%.
Peer valuation comparison
Latest P/E is 17.89x versus a Healthcare sector median of 21.69x (17.5% below).
Latest dividend yield is 2.27% versus a Healthcare sector median of 2.41% (5.8% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 660.54B | JPY 13.50B | JPY 54.66B | 31.5% | 73.36 | JPY 97.84B | JPY 641.05B | JPY 274.12B |
| FY2025 | JPY 644.59B | JPY 5.11B | JPY 68.46B | 29.6% | 27.78 | JPY 106.67B | JPY 636.87B | JPY 252.45B |
| FY2024 | JPY 586.79B | JPY 11.11B | JPY 72.94B | 29.2% | 24.85 | JPY 99.67B | JPY 635.69B | JPY 232.66B |
| FY2023 | JPY 545.20B | JPY 4.57B | JPY 10.40B | 30.0% | 24.85 | JPY 89.68B | JPY 605.93B | JPY 206.32B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 224.75B | 17.9 | 2.3% | 31 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 31 JPY, yield 2.3%.
| Year | Dividends/share |
|---|---|
| FY2026 | 31 JPY |
| FY2025 | 23 JPY |
| FY2024 | 27 JPY |
| FY2023 | 18.5 JPY |
| FY2022 | 26 JPY |
About Nipro Corporation
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses worldwide. The company offers renal products; interventional products, such as cardiovascular products, endovascular products, and accessories; and hospital products, including hypodermic needles, syringes, IV sets and catheters, 3-way stopcocks, infusion sets, balloon infusers, etc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Nipro Corporation's market cap?
Nipro Corporation's market capitalization is JPY 224.75B.
What is Nipro Corporation's P/E ratio?
Nipro Corporation's price-to-earnings (P/E) ratio is 17.9.
Does Nipro Corporation pay a dividend?
Nipro Corporation has a dividend yield of 2.3%.
What does Nipro Corporation do?
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses worldwide. The company offers renal products; interventional products, such as cardiovascular products, endovascular products, and accessories; and hospital products, including hypodermic needles, syringes, IV sets and catheters, 3-way stopcocks, infusion sets, balloon infusers, etc.